We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$282M
AUM Growth
-$3.93M
Cap. Flow
-$6.27M
Cap. Flow %
-2.23%
Top 10 Hldgs %
46%
Holding
230
New
13
Increased
66
Reduced
108
Closed
18

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$844K
2
EXP icon
Eagle Materials
EXP
+$808K
3
NVDA icon
NVIDIA
NVDA
+$712K
4
PI icon
Impinj
PI
+$675K
5
AAPL icon
Apple
AAPL
+$650K

Sector Composition

Rank Sector Weight
1 Technology 29.06%
2 Healthcare 15.37%
3 Communication Services 8.73%
4 Financials 7.38%
5 Consumer Discretionary 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
226
State Street SPDR S&P Dividend ETF
SDY
$21.8B
-1,510
Closed -$214K
SMCI icon
227
Super Micro Computer
SMCI
$15.6B
-5,150
Closed -$214K
STZ icon
228
Constellation Brands
STZ
$22.7B
-931
Closed -$240K
TD icon
229
Toronto Dominion Bank
TD
$204B
-3,258
Closed -$206K
UBER icon
230
Uber
UBER
$147B
-2,927
Closed -$220K

Similar funds

Wealth Effects's Q4 2024 Portfolio in Review

As of Q4 2024, Wealth Effects held 230 positions worth $282M, down 1.4% from $285M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Wealth Effects's Q4 2024 filing shows 13 new, 66 increased, 108 reduced and 18 closed positions. Its largest new stake was Palantir: 7,714 shares worth $583K. The largest sale was Novo Nordisk, an estimated $844K.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.

  • Wealth Effects's largest Q4 2024 buy was Palantir: 7,714 shares worth $583K.
  • Wealth Effects added most to Avadel Pharmaceuticals in Q4 2024, an estimated $1.34M increase.
  • Wealth Effects's biggest Q4 2024 reduction was Eagle Materials, cutting an estimated $808K.
  • Wealth Effects fully exited Novo Nordisk in Q4 2024, selling an estimated $844K.
  • Wealth Effects's ten largest holdings make up 46% of its $282M portfolio in Q4 2024.
  • Wealth Effects opened 13 new positions and closed 18 in Q4 2024.
  • Wealth Effects's portfolio value fell 1.4% quarter-over-quarter to $282M.

Based on Wealth Effects's 13F filing for Q4 2024, filed 22 Jan 2025.